Trametinib 0.5 mg, 1 mg, 2 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 0.5 mg, 1 mg, 2 mg
Reference Brands: Mekinist (USA/EU)
Category: Oncology Cancer Care
Trametinib is a targeted cancer therapy that inhibits MEK1 and MEK2 enzymes in the MAPK/ERK pathway, helping to slow or stop the growth of cancer cells. It is primarily used for the treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutations and can be combined with BRAF inhibitors for enhanced efficacy.
Trametinib — third party manufacturing & bulk supply
Trametinib 0.5 mg, 1 mg, 2 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Trametinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Trametinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Trametinib is used to treat certain cancers, including unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and in combination with other drugs for some non‑small cell lung cancers, thyroid cancer, certain solid tumors, and glioma with specific mutations.
Trametinib is a small‑molecule MEK inhibitor that blocks the activity of MEK1 and MEK2 enzymes in the MAPK/ERK signaling pathway, which helps prevent cancer cells from multiplying.
The trade names are Mekinist and Spexotras.
It is manufactured and marketed by the companies holding the global marketing rights, including Novartis under the trade name Mekinist.
The generic name is trametinib.
Brand names include Mekinist and Spexotras.
Trametinib is produced as an oral drug in pharmaceutical manufacturing facilities under standard regulatory practices, available as tablets or oral solution depending on patient needs.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
